Skip to main content
Clinical Trials/NCT03207685
NCT03207685
Unknown
Not Applicable

Characterizing Generalized Seizure Detection And Alerting In The Epilepsy Monitoring Unit With The Empatica Embrace Watch And Smartphone-Based Alert System

Empatica, Inc.2 sites in 2 countries100 target enrollmentJune 30, 2017
ConditionsEpilepsy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Epilepsy
Sponsor
Empatica, Inc.
Enrollment
100
Locations
2
Primary Endpoint
Comparison of Video-EEG to Embrace System
Last Updated
5 years ago

Overview

Brief Summary

To demonstrate safety and effectiveness of the Embrace device in identifying convulsive seizures (CS) and notifying a caregiver during patient hospitalization at an epilepsy monitoring unit (EMU).

Detailed Description

To demonstrate safety and effectiveness of the Embrace device in identifying convulsive seizures (CS) and notifying a caregiver during patient hospitalization at an epilepsy monitoring unit (EMU). Subjects will be fit with an Embrace device upon admittance into the EMU. The Embrace system will be used in conjunction with the EMU standard care practices to monitor the subject during the subject's stay. EMU standard care practices will not be impacted by the Embrace system, but rather the Embrace will be used to supplement the EMU monitoring. The events detected by Embrace will later be compared to the gold standard results of the video EEG. A convulsive seizure (CS) is defined for the purpose of this study as any seizure with non-facial motor activity involving one or both upper and/or lower extremities that has repetitive motor activity (rhythmic motor movements).

Registry
clinicaltrials.gov
Start Date
June 30, 2017
End Date
January 2022
Last Updated
5 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male and female patients with a history of convulsive seizure (as defined above) who are admitted to a hospital for routine vEEG monitoring related to seizures. Patients who are expected to have a convulsive seizure during their monitoring based on interpretation of clinical history.

Exclusion Criteria

  • Patients who are not expected to have their typical convulsive seizure during the course of their hospital admission (i.e. expected reduction due to anti-epileptic drugs during hospital admission).
  • Women who are pregnant.
  • Patients who are known or suspected to have a history of PNES only.
  • Patients with known allergic reactions to nickel or stainless steel
  • Infants who were born pre-term and may not have fully developed skin

Outcomes

Primary Outcomes

Comparison of Video-EEG to Embrace System

Time Frame: 6 months

Lower bound of 95% confidence interval of the positive percent agreement (PPA) greater than 70%, as determined in comparison to Video-EEG adjudicated by 3 independent expert reviewers. A majority rules approach is used to identify convulsive seizures.

Secondary Outcomes

  • False Alarm Rate Tolerability(6 months)
  • Patient Care Improvement Measure(6 months)
  • Embrace System Usability(6 months)
  • Alarm System Comparison(6 months)

Study Sites (2)

Loading locations...

Similar Trials